Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

PRQR

ProQR Therapeutics N.V.

Healthcare · USD

Set alert

Price alert · PRQR

All alert types
1.39 USD -0.05 -3.47%
As of Oct 30, 2026 Extended hours 1.41 +1.44%
Bid
1.38 × 2
Ask
1.39 × 2
1.34 Day range 1.45
1.24 52-week range 2.75
YTD
-31.19%
1 year
-48.90%
Open
1.41
Prev close
1.44
Mkt cap
196.16M
Vol
795.15K
Avg vol
859.06K
EPS
-0.45
P/E
0.00
Div yield
0.00%
More statistics
Low
1.34
High
1.45
Forward P/E
-5.68
Beta
0.25
Short ratio
0.31
Inst. own
24.96%
Dividend
0.00
Ex-div date
50-d avg
3.44
200-d avg
2.32
1y target
8.00

5D chart

Chart tools
Interval
1m5m15m30m
PRQR five-day price chart1.201.271.351.431.50Oct 26Oct 27Oct 28Oct 29Oct 30

Financial health

Altman Z-Score

-3.25 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 3
  • P/E 1
  • P/B 3

Valuation

P/E -4.5×
FY 2016: -2.8×FY 2017: -1.6×FY 2018: -12.7×FY 2019: -6.4×FY 2020: -3.7×FY 2021: -7.3×FY 2022: -3.8×FY 2023: -5.1×FY 2024: -7.5×FY 2025: -4.5×
FY 2016 5y median -5.1× FY 2025
P/S 11.9×
FY 2016: 47.6×FY 2017: -45.6×FY 2018: 94.8×FY 2019: 188×FY 2020: 167×FY 2021: 339×FY 2022: 68.9×FY 2023: 22.3×FY 2024: 11.1×FY 2025: 11.9×
FY 2016 5y median 22.3× FY 2025
P/B 3.1×
FY 2016: 1.9×FY 2017: 1.5×FY 2018: 4.4×FY 2019: 3.4×FY 2020: 2.5×FY 2021: 3.5×FY 2022: 3.5×FY 2023: 3.2×FY 2024: 2.3×FY 2025: 3.1×
FY 2016 5y median 3.2× FY 2025
P/FCF -3.4×
FY 2016: -3.0×FY 2017: -2.0×FY 2018: -15.1×FY 2019: -8.1×FY 2020: -3.6×FY 2021: -17.1×FY 2022: -3.6×FY 2023: 7.2×FY 2024: -5.5×FY 2025: -3.4×
FY 2016 5y median -3.6× FY 2025
EV/EBITDA -2.4×
FY 2016: -1.4×FY 2017: 19.4×FY 2018: -10.1×FY 2019: -1.5×FY 2020: -2.5×FY 2021: -5.6×FY 2022: -3.0×FY 2023: -1.5×FY 2024: -2.9×FY 2025: -2.4×
FY 2016 5y median -2.9× FY 2025
EV/Sales 5.8×
FY 2016: 22.4×FY 2017: -13.5×FY 2018: 72.0×FY 2019: 130×FY 2020: 118×FY 2021: 230×FY 2022: 47.3×FY 2023: 5.5×FY 2024: 3.7×FY 2025: 5.8×
FY 2016 5y median 5.8× FY 2025
FCF Yield -29.7%
FY 2016: -33.8%FY 2017: -50.3%FY 2018: -6.6%FY 2019: -12.3%FY 2020: -27.9%FY 2021: -5.9%FY 2022: -28.0%FY 2023: 13.9%FY 2024: -18.1%FY 2025: -29.7%
FY 2016 5y median -18.1% FY 2025

Profitability

Gross Margin 83.0%
FY 2016: 43.8%FY 2017: 165.5%FY 2018: 80.1%FY 2019: -5943.6%FY 2020: 100.0%FY 2021: 100.0%FY 2022: 100.0%FY 2023: 100.0%FY 2024: 100.0%FY 2025: 83.0%
FY 2016 5y median 100.0% FY 2025
Operating Margin -275.9%
FY 2016: -1734.1%FY 2017: 2648.7%FY 2018: -734.5%FY 2019: -2971.8%FY 2020: -4117.4%FY 2021: -4285.4%FY 2022: -1813.0%FY 2023: -489.1%FY 2024: -161.2%FY 2025: -275.9%
FY 2016 5y median -489.1% FY 2025
Net Margin -265.2%
FY 2016: -1713.5%FY 2017: 2854.0%FY 2018: -746.7%FY 2019: -2935.6%FY 2020: -4525.3%FY 2021: -4549.8%FY 2022: -1792.5%FY 2023: -431.7%FY 2024: -146.9%FY 2025: -265.2%
FY 2016 5y median -431.7% FY 2025
ROE -69.9%
FY 2016: -69.8%FY 2017: -92.3%FY 2018: -34.7%FY 2019: -53.6%FY 2020: -66.7%FY 2021: -46.9%FY 2022: -90.0%FY 2023: -61.5%FY 2024: -30.3%FY 2025: -69.9%
FY 2016 5y median -61.5% FY 2025
ROIC -42.3%
FY 2016: -63.8%FY 2017: -72.4%FY 2018: -31.1%FY 2019: -47.7%FY 2020: -38.1%FY 2021: -26.7%FY 2022: -39.6%FY 2023: -27.3%FY 2024: -21.9%FY 2025: -42.3%
FY 2016 5y median -27.3% FY 2025
ROA -30.6%
FY 2016: -56.6%FY 2017: -68.4%FY 2018: -29.3%FY 2019: -43.0%FY 2020: -38.5%FY 2021: -25.5%FY 2022: -35.2%FY 2023: -18.5%FY 2024: -16.0%FY 2025: -30.6%
FY 2016 5y median -25.5% FY 2025

Growth (YoY)

Revenue -19.2%
FY 2016: -75.7%FY 2017: -167.0%FY 2018: 423.2%FY 2019: -60.9%FY 2020: -46.8%FY 2021: 29.7%FY 2022: 169.2%FY 2023: 81.2%FY 2024: 190.2%FY 2025: -19.2%
FY 2016 FY 2025
Operating Income -38.3%
FY 2016: -46.6%FY 2017: -2.3%FY 2018: 10.4%FY 2019: -58.3%FY 2020: 26.2%FY 2021: -35.0%FY 2022: -13.9%FY 2023: 51.1%FY 2024: 4.4%FY 2025: -38.3%
FY 2016 FY 2025
EPS (diluted) -11.8%
FY 2016: -87.6%FY 2017: -3.0%FY 2018: 37.2%FY 2019: -27.8%FY 2020: 32.6%FY 2021: -3.2%FY 2022: 5.2%FY 2023: 61.5%FY 2024: 2.9%FY 2025: -11.8%
FY 2016 FY 2025
Free Cash Flow -42.3%
FY 2016: -43.8%FY 2017: 4.6%FY 2018: 11.6%FY 2019: -43.7%FY 2020: -7.7%FY 2021: 44.8%FY 2022: -161.2%FY 2023: 129.2%FY 2024: -287.4%FY 2025: -42.3%
FY 2016 FY 2025

Financial Health

Current Ratio 3.1×
FY 2016: 9.2×FY 2017: 6.0×FY 2018: 13.3×FY 2019: 10.4×FY 2020: 7.8×FY 2021: 6.9×FY 2022: 7.4×FY 2023: 3.5×FY 2024: 4.0×FY 2025: 3.1×
FY 2016 5y median 4.0× FY 2025
Quick Ratio 3.1×
FY 2016: 9.2×FY 2017: 6.0×FY 2018: 13.3×FY 2019: 10.4×FY 2020: 7.8×FY 2021: 6.9×FY 2022: 7.4×FY 2023: 3.5×FY 2024: 4.0×FY 2025: 3.1×
FY 2016 5y median 4.0× FY 2025
Debt / Equity 0.3×
FY 2016: 0.1×FY 2017: 0.2×FY 2018: 0.1×FY 2019: 0.1×FY 2020: 0.6×FY 2021: 0.5×FY 2022: 0.3×FY 2023: 0.5×FY 2024: 0.2×FY 2025: 0.3×
FY 2016 5y median 0.3× FY 2025
Net Debt / EBITDA 2.5×
FY 2016: 1.6×FY 2017: -46.1×FY 2018: 3.2×FY 2019: 0.6×FY 2020: 1.0×FY 2021: 2.6×FY 2022: 1.4×FY 2023: 4.5×FY 2024: 5.7×FY 2025: 2.5×
FY 2016 5y median 2.6× FY 2025
Interest Coverage -48.7×
FY 2016: -73.6×FY 2017: -67.9×FY 2018: -44.8×FY 2019: -53.0×FY 2020: -20.8×FY 2021: -16.8×FY 2022: -12.7×FY 2023: -26.5×FY 2024: -28.3×FY 2025: -48.7×
FY 2016 5y median -26.5× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31